Objectives: To present an effective system for the evaluation and surgical management of localized attic cholesteatoma, as well as describing the follow-up of patients treated at our institution. Study Design: Retrospective review of single-institution experience. Methods: A total of 71 patients (71 ears) with localized attic cholesteatoma received atticotomies. Further surgical management was then carried out according to the extent of the cholesteatoma and whether the malleoincudal joint was preserved (type I) or not (type II). There were 27 type I patients and 44 type II patients. In all 71 patients, the lateral wall of epitympanum was rebuilt with tragal cartilage. The healing of the lateral wall of the attic and the tympanic membrane as well as the recovery of hearing level were assessed after the operation. Results: The follow-up periods lasted 3–6 years, with an average of 4.5 years. The healing of the lateral wall of the epitympanum was satisfactory in all 71 patients. According to pure tone audiometry conducted after the operation, the air-bone gap was <10 dB in 43 patients, <20 dB in 23 patients, <30 dB in 4 patients, and >30 dB in only 1 patient. No vertigo or tinnitus was experienced after the operation. Conclusions: The surgical management of localized attic cholesteatoma should be planed according to the extent of the cholesteatoma and especially the condition of the malleoincudal joint. In order to prevent a subsequent retraction pocket of the attic, it is important to rebuild the lateral wall of the attic with cartilage after clearing the cholesteatoma.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.